1,3-dipropylxanthine has been researched along with isoalloxazine in 1 studies
| Studies (1,3-dipropylxanthine) | Trials (1,3-dipropylxanthine) | Recent Studies (post-2010) (1,3-dipropylxanthine) | Studies (isoalloxazine) | Trials (isoalloxazine) | Recent Studies (post-2010) (isoalloxazine) |
|---|---|---|---|---|---|
| 26 | 0 | 0 | 194 | 0 | 60 |
| Protein | Taxonomy | 1,3-dipropylxanthine (IC50) | isoalloxazine (IC50) |
|---|---|---|---|
| Female germline-specific tumor suppressor gld-1 | Caenorhabditis elegans | 1.471 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahern, DG; Jacobson, KA; Ji, X; Kim, YC; Linden, J | 1 |
1 other study(ies) available for 1,3-dipropylxanthine and isoalloxazine
| Article | Year |
|---|---|
[3H]MRS 1754, a selective antagonist radioligand for A(2B) adenosine receptors.
Topics: Acetamides; Cells, Cultured; Humans; Purinergic P1 Receptor Antagonists; Purines; Radioligand Assay; Radiopharmaceuticals; Receptor, Adenosine A2B; Tritium | 2001 |